2007
DOI: 10.1007/s10038-007-0129-2
|View full text |Cite
|
Sign up to set email alerts
|

Identification and characterization of human uracil phosphoribosyltransferase (UPRTase)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
35
0
1

Year Published

2008
2008
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(36 citation statements)
references
References 36 publications
0
35
0
1
Order By: Relevance
“…Unlike enzymes from the de novo synthesis of UMP, UPRTs have mostly been characterized in lower organisms. Human UPRT has been isolated from the human fetal brain cDNA library [18]. However cloning, expression, and purification yielded a recombinant protein with no detectable UPRT catalytic activity [18].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Unlike enzymes from the de novo synthesis of UMP, UPRTs have mostly been characterized in lower organisms. Human UPRT has been isolated from the human fetal brain cDNA library [18]. However cloning, expression, and purification yielded a recombinant protein with no detectable UPRT catalytic activity [18].…”
Section: Introductionmentioning
confidence: 99%
“…Human UPRT has been isolated from the human fetal brain cDNA library [18]. However cloning, expression, and purification yielded a recombinant protein with no detectable UPRT catalytic activity [18]. Although there appears to be no solid experimental evidence for the presence of UPRT in humans, UMP can be obtained through uridine phosphorylase [19] reaction followed by uridine kinase activity, and uridine-cytidine kinase enzyme activity [20].…”
Section: Introductionmentioning
confidence: 99%
“…DHODH is a key player in the pyrimidine de novo biosynthesis pathway and converts dihydroorotate (DHO) into orotate (24). Both the pyrimidine de novo biosynthesis pathway and the uracil salvage pathway channel into the production of uridine monophosphate (UMP) (25), which is the precursor for all pyrimidine nucleotides needed for RNA (UTP, CTP) and DNA (dTTP, dCTP) synthesis. Leflunomide (Arava) is a Food and Drug Administration (FDA)-approved therapy for rheumatoid arthritis, and its immunosuppressive properties are related to inhibition of T-cell proliferation, which is heavily reliant on pyrimidine pools (26).…”
mentioning
confidence: 99%
“…Proteins containing a Uprt domain have been reported in higher multicellular eukaryotes, including humans. However, modifications in the domain associated with uracil binding suggest that higher eukaryote orthologs diverge in function from T. gondii Uprt [43]. Indeed, assays in human and mouse cells have shown that Uprt orthologs are unable to convert uracil to UMP [22].…”
Section: Biosynthetic Labeling Of Newly Transcribed Rnamentioning
confidence: 99%